Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2009 |
| End Date: | June 2012 |
An Open-Label, Dose Escalation, Phase I Study of TAK-901 in Adult Patients With Advanced Solid Tumors or Lymphoma
This study is being conducted to evaluate the safety profile and the Maximum Tolerated Dose
(MTD) of TAK-901 in adult patients with advanced solid tumors or lymphoma. This study will
help to identify the recommended phase 2 dose and infusion duration, and describe the
pharmacokinetics of TAK-901.
We found this trial at
3
sites
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
Click here to add this to my saved trials
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health Systems The University of Michigan is home to one of the...
Click here to add this to my saved trials
Click here to add this to my saved trials